A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), has demonstrated in cell cultures that it can neutralize the toxin pyocyanin produced by the bacterium Pseudomonas aeruginosa, which the World Health Organization considers highly dangerous due to its strong resistance to nearly all antibiotics and its prevalence in hospital settings.
This article was originally published on MedicalXpress.com
